Prof Anthony Moorman is sharing his views on clinic data in
Video: What is Big Data for Better Outcomes and what
At 19 June 2018 the Innovative Medicines Initiative
To read: The Future of Patient Data Report
IMI is celebrating its 10th anniversary. We are proud to be
Real-world data (RWD) is health-related data derived from
Big Data has been attributed as having “transformative ...
Read the IMI interview with HARMONY Partners Jan
@HARMONY Talks: Partners, Work Package Leaders and Leaders
@HARMONY Talks: Partners, Work Package Leaders and Leaders
HARMONY presented at the Fifth Annual Life Science R&D Data
EU’s Health Commissioner Andriukaitis: Big data has ‘enormous’ ...
HARMONY in the new open access journal of the European Hematology ...
Advancing a field by building consortia: The example of the
We are looking forward to another exciting and productive
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands